NCT04191057Completed
Determining Normal Range for Free Light Chains in Serum Among Twins
Normal Range Study for Free Light Chains in Blood Among Identical or Fraternal Twins
Source: ClinicalTrials.gov · Last updated 14 Jan 2025
Brief summary (registry, in English)
The objective of this study is to recruit healthy adult identical and fraternal twins for the collection of one teaspoon of blood to be sent to the Clinical Lab at San Francisco General Hospital. The serum will be tested to determine the reference range for free light chains.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 32 (actual)
- First submitted
- 5 Dec 2019
- Start date
- 15 Aug 2018
- Primary completion date
- 1 Jan 2024
- Lead sponsor
- University of California, San Francisco
- Diseases
- Multiple myeloma
- NCT number
- NCT04191057
What you commit to
- Study type: Interventional
- Participants enrolled: 32
- From 15 Aug 2018 to the primary completion date, 1 Jan 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Symptoms suggestive of multiple myeloma (e.g., renal insufficiency, anemia, bone pain) -
Who the study is looking for
- Healthy subjects 18-80 years.
- Must be an identical or fraternal twin (both must be recruited)
Age in the registry: 18 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| San Francisco General Hospital Coordinator of this site? Confirm its status | San Francisco | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.